Cutler Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $66K | Buy |
+440
| New | +$66K | 0.02% | 327 |
|
|
2023
Q4 | – | Sell |
-200
| Closed | -$18K | – | 1313 |
|
|
2023
Q3 | $18K | Sell |
200
-460
| -70% | -$41.4K | ﹤0.01% | 900 |
|
|
2023
Q2 | $58K | Buy |
660
+510
| +340% | +$44.8K | 0.01% | 578 |
|
|
2023
Q1 | $16K | Sell |
150
-50
| -25% | -$5.33K | ﹤0.01% | 892 |
|
|
2022
Q4 | $24K | Buy |
+200
| New | +$24K | ﹤0.01% | 1033 |
|
|
2022
Q3 | – | Sell |
-1,772
| Closed | -$164K | – | 1910 |
|
|
2022
Q2 | $164K | Sell |
1,772
-7,883
| -82% | -$730K | 0.01% | 515 |
|
|
2022
Q1 | $1.13M | Buy |
+9,655
| New | +$1.13M | 0.06% | 195 |
|
|
2021
Q4 | – | Sell |
-150
| Closed | -$23K | – | 2053 |
|
|
2021
Q3 | $23K | Buy |
+150
| New | +$23K | ﹤0.01% | 1480 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2109 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2028 |
|
|
2020
Q4 | – | Sell |
-420
| Closed | -$64K | – | 1775 |
|
|
2020
Q3 | $64K | Buy |
+420
| New | +$64K | ﹤0.01% | 810 |
|
|
2020
Q2 | – | Sell |
-2,000
| Closed | -$225K | – | 1549 |
|
|
2020
Q1 | $225K | Buy |
+2,000
| New | +$225K | 0.01% | 388 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1503 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1484 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1570 |
|
|
2019
Q1 | – | Sell |
-1,200
| Closed | -$75K | – | 1497 |
|
|
2018
Q4 | $75K | Buy |
+1,200
| New | +$75K | 0.01% | 726 |
|
|
2018
Q3 | – | Sell |
-800
| Closed | -$53K | – | 1610 |
|
|
2018
Q2 | $53K | Buy |
+800
| New | +$53K | ﹤0.01% | 885 |
|